Replies to post #235927 on Biotech Values

[crudeoil24]

SNSS @ 4.70 up 32% > Sunesis Pharmaceuticals shares are trading higher after Oppenheimer upgraded the stock from Perform to Outperform and announced a price target of $12 per share.

Feb 23, 2021 8:03a ETBenzinga Stock Analysis

[DewDiligence]

SNSS begins trading as VIRX tomorrow:

https://finance.yahoo.com/news/viracta-therapeutics-announces-closing-merger-210500472.html